These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 35174096)
1. Imaging Glioblastoma With Scarpelli ML; Healey DR; Mehta S; Quarles CC Front Oncol; 2022; 12():829050. PubMed ID: 35174096 [TBL] [Abstract][Full Text] [Related]
2. Correlation between Saarinen I; Jambor I; Kim M; Kuisma A; Kemppainen J; Merisaari H; Eskola O; Koskenniemi AR; Perez IM; Boström P; Taimen P; Minn H EJNMMI Res; 2019 May; 9(1):50. PubMed ID: 31152256 [TBL] [Abstract][Full Text] [Related]
3. [(14)C]Fluciclovine (alias anti-[(14)C]FACBC) uptake and ASCT2 expression in castration-resistant prostate cancer cells. Ono M; Oka S; Okudaira H; Nakanishi T; Mizokami A; Kobayashi M; Schuster DM; Goodman MM; Shirakami Y; Kawai K Nucl Med Biol; 2015 Nov; 42(11):887-92. PubMed ID: 26278491 [TBL] [Abstract][Full Text] [Related]
4. Exploratory Analysis of Serial Fatania K; Frood R; Tyyger M; McDermott G; Fernandez S; Shaw GC; Boissinot M; Salvatore D; Ottobrini L; Teh I; Wright J; Bailey MA; Koch-Paszkowski J; Schneider JE; Buckley DL; Murray L; Scarsbrook A; Short SC; Currie S Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884545 [TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
6. Michaud L; Beattie BJ; Akhurst T; Dunphy M; Zanzonico P; Finn R; Mauguen A; Schöder H; Weber WA; Lassman AB; Blasberg R Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1353-1367. PubMed ID: 31418054 [TBL] [Abstract][Full Text] [Related]
7. 18F-Fluciclovine PET metabolic imaging reveals prostate cancer tumour heterogeneity associated with disease resistance to androgen deprivation therapy. Malviya G; Patel R; Salji M; Martinez RS; Repiscak P; Mui E; Champion S; Mrowinska A; Johnson E; AlRasheedi M; Pimlott S; Lewis D; Leung HY EJNMMI Res; 2020 Nov; 10(1):143. PubMed ID: 33237350 [TBL] [Abstract][Full Text] [Related]
8. Phase IIa clinical study of [ Kondo A; Ishii H; Aoki S; Suzuki M; Nagasawa H; Kubota K; Minamimoto R; Arakawa A; Tominaga M; Arai H Ann Nucl Med; 2016 Nov; 30(9):608-618. PubMed ID: 27418267 [TBL] [Abstract][Full Text] [Related]
9. Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory Study. Tade FI; Cohen MA; Styblo TM; Odewole OA; Holbrook AI; Newell MS; Savir-Baruch B; Li X; Goodman MM; Nye JA; Schuster DM J Nucl Med; 2016 Sep; 57(9):1357-63. PubMed ID: 27056619 [TBL] [Abstract][Full Text] [Related]
10. Albano D; Tomasini D; Bonù M; Giubbini R; Bertagna F Ann Nucl Med; 2020 Feb; 34(2):81-86. PubMed ID: 31773466 [No Abstract] [Full Text] [Related]
11. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers. Ulaner GA; Goldman DA; Gönen M; Pham H; Castillo R; Lyashchenko SK; Lewis JS; Dang C J Nucl Med; 2016 Sep; 57(9):1350-6. PubMed ID: 26940766 [TBL] [Abstract][Full Text] [Related]
12. Determining the extent of tumor resection at surgical planning with Wakabayashi T; Hirose Y; Miyake K; Arakawa Y; Kagawa N; Nariai T; Narita Y; Nishikawa R; Tsuyuguchi N; Fukami T; Sasaki H; Sasayama T; Kondo A; Iuchi T; Matsuda H; Kubota K; Minamimoto R; Terauchi T; Nakazato Y; Kubomura K; Wada M Ann Nucl Med; 2021 Dec; 35(12):1279-1292. PubMed ID: 34406623 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis of Brain Tumors Using Amino Acid Transport PET Imaging with Tsuyuguchi N; Terakawa Y; Uda T; Nakajo K; Kanemura Y Asia Ocean J Nucl Med Biol; 2017; 5(2):85-94. PubMed ID: 28660218 [TBL] [Abstract][Full Text] [Related]
14. Understanding and Improving Lowentritt BH; Kipper MS Prostate Cancer; 2020; 2020():1929565. PubMed ID: 32395349 [TBL] [Abstract][Full Text] [Related]
15. Regional distribution and kinetics of [18F]fluciclovine (anti-[18F]FACBC), a tracer of amino acid transport, in subjects with primary prostate cancer. Sörensen J; Owenius R; Lax M; Johansson S Eur J Nucl Med Mol Imaging; 2013 Feb; 40(3):394-402. PubMed ID: 23208700 [TBL] [Abstract][Full Text] [Related]
16. Distinguishing Progression from Pseudoprogression in Glioblastoma Using Nabavizadeh A; Bagley SJ; Doot RK; Ware JB; Young AJ; Ghodasara S; Zhao C; Anderson H; Schubert E; Carpenter EL; Till J; Henderson F; Pantel AR; Chen HI; Lee JYK; Amankulor NM; O'Rourke DM; Desai A; Nasrallah MP; Brem S J Nucl Med; 2023 Jun; 64(6):852-858. PubMed ID: 36549916 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic Performance and Safety of Positron Emission Tomography Using Wakabayashi T; Iuchi T; Tsuyuguchi N; Nishikawa R; Arakawa Y; Sasayama T; Miyake K; Nariai T; Narita Y; Hashimoto N; Okuda O; Matsuda H; Kubota K; Ito K; Nakazato Y; Kubomura K Asia Ocean J Nucl Med Biol; 2017; 5(1):10-21. PubMed ID: 28840134 [TBL] [Abstract][Full Text] [Related]
18. Multimodal Karlberg A; Berntsen EM; Johansen H; Myrthue M; Skjulsvik AJ; Reinertsen I; Esmaeili M; Dai HY; Xiao Y; Rivaz H; Borghammer P; Solheim O; Eikenes L World Neurosurg; 2017 Dec; 108():989.e1-989.e8. PubMed ID: 28844925 [TBL] [Abstract][Full Text] [Related]
19. Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer. Chu CE; Alshalalfa M; Sjöström M; Zhao SG; Liu Y; Chou J; Herlemann A; Mahal B; Kishan AU; Spratt DE; Cooperberg M; Small E; Wong A; Porten S; Hope TA; Ross AE; Davicioni E; Nguyen P; Karnes RJ; Carroll PR; Schaeffer E; Feng FY Eur Urol; 2021 Jun; 79(6):717-721. PubMed ID: 33840559 [No Abstract] [Full Text] [Related]